Observational Study to Evaluate, Under Real-world Practice Conditions, the Safety and Effectiveness of Regorafenib in Patients Diagnosed With Unresectable Hepatocellular Carcinoma (uHCC)

Gilbert, Arizona 85234, United States

Phoenix, Arizona 85013, United States

Gainesville, Florida 32610, United States

Louisville, Kentucky 40202, United States

New Orleans, Louisiana 70112, United States

Baltimore, Maryland 21202, United States

Ann Arbor, Michigan 48109, United States

Detroit, Michigan 48202, United States

Rochester, Minnesota 55905, United States

Newark, New Jersey 07101-1709, United States

Buffalo, New York 14263, United States

Glens Falls, New York 12801, United States

Cincinnati, Ohio 45267, United States

Philadelphia, Pennsylvania 19104, United States

Philadelphia, Pennsylvania 19141, United States

Dallas, Texas 75390, United States

Houston, Texas 77030, United States

Multiple Locations, Argentina

Multiple Locations, Austria

Multiple Locations, Belgium

Multiple Locations, Canada

Multiple Locations, China

Multiple Locations, Denmark

Multiple Locations, Egypt

Multiple Locations, France

Multiple Locations, Greece

Multiple Locations, Italy

Multiple Locations, Japan

Multiple Locations, Netherlands

Multiple Locations, Russia

Multiple Locations, Saudi Arabia

Multiple Locations, South Korea

Multiple Locations, Spain

Multiple Locations, Sweden

Multiple Locations, Taiwan

Multiple Locations, Thailand

Multiple Locations, Turkey (Türkiye)